State Street Corp Casi Pharmaceuticals, Inc. Transaction History

State Street Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	SELL	$1.63 - $2.32 $57,954 - $82,487	-35,555 Closed	0 $0
Q2 2022 Aug 15, 2022	BUY	$2.85 - $7.1 $101,331 - $252,440	35,555 New	35,555 $102,000

Ticker CASI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,606,100
Market Cap $69.4M
Description
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.